You need JavaScript to view this

Patient dose assessment in different diagnostic procedures in nuclear medicine

Abstract

Effective doses have been estimated for 314 patients under diagnostic procedures in a Nuclear Medicine Department using data reported in ICRP-80 and RIDIC (Radiation Internal Dose Information Center). Data on administered activity, radiopharmaceutical and administration route, age and sex of the patients have been collected. Doses in the most exposed critical organ for every protocol, doses in uterus, doses in fetus versus the stage of pregnancy (in case the female patient was pregnant) and doses for nursing infants have been also estimated. Ga-67 studies give the highest effective doses per protocol followed by cardiac SPECT procedures using Tl-201 chloride. Ga-67 studies also give the highest absorbed doses in uterus. Due to not administering different activities, depending on height and weight of adults, women receive doses about 20% higher than men. This would be a practice to modify in the future in order to optimise doses. (author)
Authors:
Sena, E de; Bejar, M J; Berenguer, R; [1]  Ruano, R; Tamayo, P [2] 
  1. Servicio de Radiofisica y Proteccion Radiologica, Salamanca (Spain)
  2. Servicio de Medicina Nuclear, Hospital Universitario de Salamanca (Spain)
Publication Date:
Mar 01, 2001
Product Type:
Conference
Report Number:
IAEA-CSP-7/P; IAEA-CN-85-192
Reference Number:
EDB-01:078293
Resource Relation:
Conference: International conference on radiological protection of patients in diagnostic and interventional radiology, nuclear medicine and radiotherapy, Malaga (Spain), 26-30 Mar 2001; Other Information: 15 refs, 4 tabs; PBD: Mar 2001; Related Information: In: Radiological protection of patients in diagnostic and interventional radiology, nuclear medicine and radiotherapy. Contributed papers, C and S papers series no. 7/P, 916 pages.
Subject:
61 RADIATION PROTECTION AND DOSIMETRY; BIOMEDICAL RADIOGRAPHY; GALLIUM 67; NUCLEAR MEDICINE; PATIENTS; RADIATION DOSES; RADIATION PROTECTION; RADIOPHARMACEUTICALS; THALLIUM 201
OSTI ID:
20185737
Research Organizations:
International Atomic Energy Agency, Vienna (Austria); European Commission, Brussels (Belgium); Pan American Health Organization, Washington, DC (United States); World Health Organization, Geneva (Switzerland)
Country of Origin:
IAEA
Language:
Spanish
Other Identifying Numbers:
Other: ISSN 1563-0153; TRN: XA0101670039893
Availability:
Available from INIS in electronic form
Submitting Site:
INIS
Size:
page(s) 374-378
Announcement Date:
Sep 14, 2001

Citation Formats

Sena, E de, Bejar, M J, Berenguer, R, Ruano, R, and Tamayo, P. Patient dose assessment in different diagnostic procedures in nuclear medicine. IAEA: N. p., 2001. Web.
Sena, E de, Bejar, M J, Berenguer, R, Ruano, R, & Tamayo, P. Patient dose assessment in different diagnostic procedures in nuclear medicine. IAEA.
Sena, E de, Bejar, M J, Berenguer, R, Ruano, R, and Tamayo, P. 2001. "Patient dose assessment in different diagnostic procedures in nuclear medicine." IAEA.
@misc{etde_20185737,
title = {Patient dose assessment in different diagnostic procedures in nuclear medicine}
author = {Sena, E de, Bejar, M J, Berenguer, R, Ruano, R, and Tamayo, P}
abstractNote = {Effective doses have been estimated for 314 patients under diagnostic procedures in a Nuclear Medicine Department using data reported in ICRP-80 and RIDIC (Radiation Internal Dose Information Center). Data on administered activity, radiopharmaceutical and administration route, age and sex of the patients have been collected. Doses in the most exposed critical organ for every protocol, doses in uterus, doses in fetus versus the stage of pregnancy (in case the female patient was pregnant) and doses for nursing infants have been also estimated. Ga-67 studies give the highest effective doses per protocol followed by cardiac SPECT procedures using Tl-201 chloride. Ga-67 studies also give the highest absorbed doses in uterus. Due to not administering different activities, depending on height and weight of adults, women receive doses about 20% higher than men. This would be a practice to modify in the future in order to optimise doses. (author)}
place = {IAEA}
year = {2001}
month = {Mar}
}